跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 73 条关于
“Porphyria”
全部
73
临床试验
51
药物
5
机构
0
资讯
17
去年
Givlaari Demonstrates Effectiveness in AIP Patients Often Excluded from Clinical Trials
去年
FDA Aligns with Gemini Therapeutics on APOLLO Trial Design for Bitopertin in Rare Porphyria Disorders
去年
Givlaari Approved in Switzerland for Acute Hepatic Porphyria Treatment
去年
FDA Approves Alnylam's Oxlumo as First Treatment for Ultra-Rare Kidney Disease PH1
9个月前
FDA Official's Skepticism Triggers Disc Medicine Stock Decline Amid Bitopertin Review
去年
Patient-Researcher's Journey Leads to Breakthrough Treatment for Rare Light Sensitivity Disorder
去年
Aera Therapeutics Names Bill Querbes as Chief Scientific Officer to Advance Genetic Medicine Pipeline
2个月前
SCENESSE® (Afamelanotide) Approved by Health Canada for Erythropoietic Protoporphyria
9个月前
FDA Launches Commissioner's National Priority Voucher Program to Accelerate Critical Drug Reviews
11个月前
FDA Approves First Drug Under New Priority Voucher Program, Fast-Tracking Augmentin XR to Strengthen US Manufacturing
第 1 页,共 2 页
上一页
下一页